Related Experiment Videos
Genetic analysis of treated and untreated phenylketonuria in one family
L A Tyfield1, A L Meredith, M J Osborn
1Department of Clinical Chemistry, Southmead Hospital, Westbury-on-Trym, Bristol.
Insights
This study identifies novel mutations in phenylalanine metabolism disorders within a single family, revealing varied biochemical phenotypes. Genetic analysis uncovered four independent mutant alleles, challenging current understanding of phenylketonuria (PKU).
Area of Science:
- Biochemistry
- Human Genetics
- Metabolic Disorders
Background:
- Disorders of phenylalanine metabolism, including phenylketonuria (PKU), are typically caused by mutations in the phenylalanine hydroxylase (PAH) gene.
- Genetic heterogeneity can lead to diverse clinical presentations, even within the same family.
- Understanding the genetic basis of metabolic disorders is crucial for accurate diagnosis and management.
Purpose of the Study:
- To investigate the genetic basis of a phenylalanine metabolism disorder in a multi-generational family with varied biochemical phenotypes.
- To identify novel mutations and understand their correlation with clinical presentations.
- To explore the genetic diversity contributing to hyperphenylalaninemia.
Main Methods:
- Biochemical analysis of phenylalanine metabolism.
- DNA analysis utilizing Restriction Fragment Length Polymorphism (RFLP) haplotypes.
- Family-based genetic studies to trace inheritance patterns.
Main Results:
- Four family members across two generations presented with phenylalanine metabolism disorders, exhibiting different neonatal biochemical phenotypes.
- DNA analysis identified four independent mutant PKU alleles distributed across three distinct haplotype patterns within the family.
- None of the affected individuals carried previously defined mutations at the phenylalanine hydroxylase (PAH) locus, indicating novel genetic variations.
Conclusions:
- The study highlights the presence of previously unidentified mutations in the PAH gene contributing to phenylalanine metabolism disorders.
- The diverse biochemical phenotypes observed in affected family members are not explained by known mutations, suggesting complex genetic interactions or novel variants.
- Further research is needed to elucidate the specific novel mutations and their impact on phenylalanine hydroxylase activity and clinical outcomes.
Abstract:
We describe a family in which four subjects in two generations have a disorder of phenylalanine metabolism. Two first cousins had different biochemical presentations in the neonatal period. The older child was thought to have a more severe form of phenylketonuria (PKU), and the younger child a milder form. While carrying out family studies we discovered that their mutual grandfather and his older unmarried brother, both of normal intelligence, had a marked and previously undiagnosed hyperphenylalaninaemia. DNA analysis using RFLP haplotypes has shown that there are four independent mutant PKU alleles in this family which are found on three haplotype patterns. None of the affected family members carries a previously defined mutation at the phenylalanine hydroxylase (PAH) locus and so DNA analysis was not able to explain the apparently different biochemical phenotypes in the affected members of this family.